Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Unum Therapeutics Inc (UMRX)

Unum Therapeutics Inc (UMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics Globe NewsWire - Mon Aug 31, 2020

PRAGUE, Czech Republic and CAMBRIDGE, Mass., Aug. 31, 2020 (GLOBE NEWSWIRE) -- SOTIO , a clinical stage immuno-oncology company owned by PPF Group, today announced that it has acquired the rights...

UMRX : 2.35 (+0.43%)
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Unum Therapeutics Inc. for Potential Breach of Fiduciary Duty Claims Globe NewsWire - Mon Jun 15, 2020

NEW YORK, June 15, 2020 (GLOBE NEWSWIRE) -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Unum Therapeutics Inc. (NASDAQ:...

UMRX : 2.35 (+0.43%)
Unum Therapeutics Reports First Quarter Financial Results and Provides Corporate Updates Globe NewsWire - Mon May 11, 2020

CAMBRIDGE, Mass., May 11, 2020 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a biopharmaceutical company focused on developing curative cell therapies for solid tumors, today announced financial...

UMRX : 2.35 (+0.43%)

Barchart Exclusives

2 Uranium Stocks With 50% or More Upside Potential Barchart - Sat May 4, 8:15AM CDT
As U.S. passes the bill to ban uranium import from Russia, U.S. based uranium companies are sure to enjoy the increased demand. Here are 2 stocks with upside according to analysts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot